<DOC>
	<DOCNO>NCT02929420</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Xiaoru Sanjie capsule treatment cyclomastopathy .</brief_summary>
	<brief_title>A Clinical Study Efficacy Safety Treatment Hyperplasia Mammary Glands With Xiaoru Sanjie Capsule</brief_title>
	<detailed_description>This multicenter , randomize , open parallel control clinical study .</detailed_description>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Fibrocystic Breast Disease</mesh_term>
	<mesh_term>Breast Diseases</mesh_term>
	<criteria>1865 year old female patient cyclomastopathy sign write informed consent . The subject voluntarily enter clinical observation hospitalize patient outpatient good compliance . They specific symptom , distend pain breast , stab pain , dull pain radiate pain . They specific physical sign , example , touch block gland , granular , nodular cord like gland etc.. Breast ultrasound molybdenum target show IIII class Breast Imaging Reporting Data System . Women pregnant lactating , history periarthritis shoulder . Excluding breast fibrocellular tumor , breast cancer breast disease . Patients poor self coordination , mentally retarded patient , cardiovascular cerebrovascular disease , severe organic disease , well hematopoietic system disease mental illness . Be judge middle degree depression Hamilton 's depression scale . Allergic constitution patient , people allergic variety drug . Any medical history may interfere test result increase risk patient accord investigator . Patients receive treatment disease , treatment method target may impact indicator study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Multicenter</keyword>
	<keyword>randomize</keyword>
	<keyword>open</keyword>
	<keyword>parallel control</keyword>
</DOC>